Volumen | 63.395 |
|
|||||
News | - | ||||||
Tageshoch | 2,00 | Niedrig Hoch |
|||||
Tagestief | 1,90 |
Name | Symbol | Markt | Aktientyp |
---|---|---|---|
Cognition Therapeutics Inc | CGTX | NASDAQ | Common Stock |
Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
---|---|---|---|---|
1,95 | 1,90 | 2,00 | 1,93 | 1,98 |
Trades | Volumen | VWAP | Finanzielles Volumen | Durchsch. Volumen | 52 Week Range |
---|---|---|---|---|---|
501 | 63.395 | US$ 1,94 | US$ 123.175 | - | 0,9001 - 3,49 |
Letzte Trade | Typ | Menge | Kurs | Währung |
---|---|---|---|---|
23:43:29 | 1 | US$ 2,02 | USD |
Finanzwerte CGTX
Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
---|---|---|---|---|---|---|
59,01M | 30,42M | - | 0 | -25,79M | -0,85 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News Cognition Therapeutics
Datum | Zeit | Quelle | Überschrift |
---|---|---|---|
11.3.2024 | 21:11 | Edgar (US Regulatory) | Form 8-K - Current report |
11.3.2024 | 21:06 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
20.2.2024 | 22:44 | Edgar (US Regulatory) | Form 8-K - Current report |
20.2.2024 | 22:13 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
20.2.2024 | 22:13 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
10.2.2024 | 01:12 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
19.1.2024 | 21:07 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
09.1.2024 | 06:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
08.1.2024 | 22:11 | Edgar (US Regulatory) | Form 424B4 - Prospectus [Rule 424(b)(4)] |
04.1.2024 | 22:21 | Edgar (US Regulatory) | Form 8-K - Current report |
04.1.2024 | 13:30 | GlobeNewswire Inc. | Cognition Therapeutics CEO Issues Letter to Shareholders |
29.12.2023 | 22:02 | Edgar (US Regulatory) | Form S-3 - Registration statement under Securities Act of.. |
Forum Cognition Therapeutics
Keine Diskussionen Gefunden.Neuen Thread Erstellen
CGTX Historisch
Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
---|---|---|---|---|---|---|---|
1 Woche | 1,93 | 2,03 | 1,87 | 1,94 | 68.620 | 0,00 | 0,00% |
1 Monat | 1,93 | 2,1599 | 1,79 | 1,97 | 121.361 | 0,00 | 0,00% |
3 Monate | 2,25 | 2,43 | 1,75 | 1,95 | 207.324 | -0,32 | -14,22% |
6 Monate | 1,06 | 2,79 | 0,9001 | 1,90 | 192.058 | 0,87 | 82,08% |
1 Jahr | 1,57 | 3,49 | 0,9001 | 1,91 | 156.879 | 0,36 | 22,93% |
3 Jahre | 12,15 | 13,80 | 0,9001 | 3,08 | 164.063 | -10,22 | -84,12% |
5 Jahre | 12,15 | 13,80 | 0,9001 | 3,08 | 164.063 | -10,22 | -84,12% |